A Stanford University initiative to make MRI equipment more child-friendly has led to the development of smaller, more lightweight coils that could have positive implications for patients both young and old, according to a recent Q&A.

One Medical Group, a primary care group with offices in San Francisco, New York, Seattle and other cities, has closed a $350 million investment from the Carlyle Group, a private equity group based in Washington, D.C., TechCrunch reported.

Medicare overpaid hospitals as much as $25.8 million for intensity-modulated radiation therapy (IMRT) planning services, according to an audit conducted by the Office of Inspector General (OIG) of HHS.

Medicare could be saving a lot of cash by switching to generic constituents for some drugs—maybe as much as a billion dollars.
A recent study estimated spending in 2016 on 29 brand-name combination products would have been $925 million more than spending for generic counterparts.

Most hospital executives and directors—nearly three in every five—believe Amazon will have the biggest impact in the healthcare market, according to a survey conducted by Reaction Data.

The same investigators who ignited debate among interventional cardiologists with the ORBITA trial in November 2017 have now published a small study highlighting the ability of percutaneous coronary intervention (PCI) to immediately reduce ischemia and boost patients’ exercise capacity.

For patients with Alzheimer’s disease, amyloid PET imaging can improve diagnosis, diagnostic confidence and treatment, according to a JAMA Neurology study. The method is beneficial whether results are positive or negative.

Researchers from Stanford University may expand current treatment options for osteoarthritis patients by using dual MRI-PET technology to detect increased bone remodeling as an early marker of bone degeneration.  

Stanford researchers are redefining the effort to catch osteoarthritis early with a combination of MRI and PET imaging, opening the field up to more noninvasive options for evaluating bone health, according to a study published online in Osteoarthritis and Cartilage.

Screening mammography is a reasonable surveillance tool for breast cancer patients treated with mastectomy and breast reconstruction with autologous myocutaneous flaps (AMFs), according to new research published in Radiology. Mammography provides little additional value, however, if the patient had reconstruction after a prophylactic mastectomy.